Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omeprazole Effects on Fructose Kinetics in MASLD (MARTINI)
NCT06539494Phase 2Recruiting
- Sponsor
- University of Amsterdam
- Start
- Jul 2024
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of omeprazole in metabolic dysfunction-associated steatotic liver disease (MASLD), sponsored by University of Amsterdam. Started Jul 2024; status: recruiting.
02
Drugs
omeprazole
03
Conditions
metabolic dysfunction-associated steatotic liver disease (MASLD)
Beyond the preview
Go deeper on NCT06539494.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06539494.